chevron_leftBack
X
As of 5 June 2026, XORTX Therapeutics, Inc. has a market cap of $3.03M USD, ranking #46131 globally and #2287 in Canada.
It ranks #4087 in the Healthcare sector, and #1307 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$3.03MUSD
4.21M CAD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.6% | -11% | -27% | -6% | -34% | -56% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
XRTX
ISIN: CA98420Q4051
Shares Out.:
Shares Outstanding:
1.392M1
Shares Float:
1.25M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2.82 CAD | |
|
XRTX
ISIN: CA98420Q4051
|
3.31 CAD | |
|
NASDAQ
MIC: XNAS
|
XRTX
ISIN: CA98420Q4051
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.25 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: XENE
|
$5.39B
178K%
|
-
|
|
TSX: GUD
|
$521.69M
17K%
725.1M CAD
|
-
|
|
NASDAQ: MIST
|
$223.22M
7K%
|
-
|
|
TSX: MSCL
|
$156.02M
5K%
216.85M CAD
|
-
|
|
TSXV: RX
|
$119.33M
4K%
165.86M CAD
|
18.5
|
|
TSX: HBP
|
$111.0M
4K%
154.28M CAD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
25M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
18M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
12M%
|
97.4
|
|
SIX: RO
|
$324.68B
11M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
10M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
9M%
218.9B CHF
|
20.5
|
chevron_leftBack